Literature DB >> 7630635

Codeletion of p15 and p16 in primary malignant mesothelioma.

S Xio1, D Li, J Vijg, D J Sugarbaker, J M Corson, J A Fletcher.   

Abstract

The p15 and p16 CDK4 inhibitor genes map within the chromosome band 9p21 region deleted frequently in malignant mesothelioma and other cancers. p16 has been implicated recently as a potential target of 9p21 deletions in mesothelioma, but the role of this gene is uncertain because deletions have been detected more often in established cell lines than in primary tumor specimens. We determined p15 and p16 copy number by fluorescence in situ hybridization with a P1 contig in 50 primary mesotheliomas. Codeletion of p15 and p16 was found in 72% of mesotheliomas, including all cases with spindle-cell components (n = 21) and total deletion of p15 and p16 was found in several mesotheliomas that lacked cytogenetic deletion of the chromosome 9 short arm. Point mutations were not found, however, in exon 2 of retained p15 and p16 alleles from seven mesotheliomas. These findings demonstrate that p15, p16 and/or a closely neighboring gene, are the targets of frequent chromosome 9p deletion in primary malignant mesothelioma.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7630635

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  41 in total

1.  Molecular pathways: targeting mechanisms of asbestos and erionite carcinogenesis in mesothelioma.

Authors:  Michele Carbone; Haining Yang
Journal:  Clin Cancer Res       Date:  2011-11-07       Impact factor: 12.531

2.  Syntenic relationships between genomic profiles of fiber-induced murine and human malignant mesothelioma.

Authors:  Didier Jean; Emilie Thomas; Elodie Manié; Annie Renier; Aurélien de Reynies; Céline Lecomte; Pascal Andujar; Jocelyne Fleury-Feith; Françoise Galateau-Sallé; Marco Giovannini; Jessica Zucman-Rossi; Marc-Henri Stern; Marie-Claude Jaurand
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

3.  Fluorescence in situ hybridization evaluation of chromosome deletion patterns in prostate cancer.

Authors:  S F Huang; S Xiao; A A Renshaw; K R Loughlin; T J Hudson; J A Fletcher
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

4.  Germline mutation of Bap1 accelerates development of asbestos-induced malignant mesothelioma.

Authors:  Jinfei Xu; Yuwaraj Kadariya; Mitchell Cheung; Jianming Pei; Jacqueline Talarchek; Eleonora Sementino; Yinfei Tan; Craig W Menges; Kathy Q Cai; Samuel Litwin; Hongzhuang Peng; Jayashree Karar; Frank J Rauscher; Joseph R Testa
Journal:  Cancer Res       Date:  2014-06-13       Impact factor: 12.701

Review 5.  The biomolecular era for thoracic surgeons: the example of the ESTS Biology Club.

Authors:  Isabelle Opitz; Thomas A D'Amico; Gaetano Rocco
Journal:  J Thorac Dis       Date:  2014-05       Impact factor: 2.895

6.  New strategies in pleural mesothelioma: BAP1 and NF2 as novel targets for therapeutic development and risk assessment.

Authors:  Marc Ladanyi; Marjorie G Zauderer; Lee M Krug; Tatsuo Ito; Robert McMillan; Matthew Bott; Filippo Giancotti
Journal:  Clin Cancer Res       Date:  2012-07-23       Impact factor: 12.531

7.  Integrated high-resolution array CGH and SKY analysis of homozygous deletions and other genomic alterations present in malignant mesothelioma cell lines.

Authors:  Geula Klorin; Ester Rozenblum; Oleg Glebov; Robert L Walker; Yoonsoo Park; Paul S Meltzer; Ilan R Kirsch; Frederic J Kaye; Anna V Roschke
Journal:  Cancer Genet       Date:  2013-07-05

8.  Prognostic significance of p16/cdkn2a loss in pleural malignant mesotheliomas.

Authors:  Sanja Dacic; Hannelore Kothmaier; Stephanie Land; Yongli Shuai; Iris Halbwedl; Patrizia Morbini; Bruno Murer; Camilla Comin; Françoise Galateau-Salle; Funda Demirag; Handan Zeren; Richard Attanoos; Alan Gibbs; Philip Cagle; Helmut Popper
Journal:  Virchows Arch       Date:  2008-10-29       Impact factor: 4.064

9.  Inactivation of Tp53 and Pten drives rapid development of pleural and peritoneal malignant mesotheliomas.

Authors:  Eleonora Sementino; Craig W Menges; Yuwaraj Kadariya; Suraj Peri; Jinfei Xu; Zemin Liu; Richard G Wilkes; Kathy Q Cai; Frank J Rauscher; Andres J Klein-Szanto; Joseph R Testa
Journal:  J Cell Physiol       Date:  2018-06-15       Impact factor: 6.384

10.  Second generation sequencing of the mesothelioma tumor genome.

Authors:  Raphael Bueno; Assunta De Rienzo; Lingsheng Dong; Gavin J Gordon; Colin F Hercus; William G Richards; Roderick V Jensen; Arif Anwar; Gautam Maulik; Lucian R Chirieac; Kim-Fong Ho; Bruce E Taillon; Cynthia L Turcotte; Robert G Hercus; Steven R Gullans; David J Sugarbaker
Journal:  PLoS One       Date:  2010-05-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.